Chemometric technologies behind Alphachrom chromatographic analyzer

来源 :第2届大连国际色谱学术报告会、第37届国际高效液相色谱及相关技术会议、第18届全国色谱学术报告会 | 被引量 : 0次 | 上传用户:feierdalong
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  A set of unique chemometric technologies are used for conversion of Microcolumn Liquid Chromatograph Alphachrom (MiLiChrom A-02) into chromatographic analyzer for pharmaceutical and forensic applications.This chromatograph is equipped with fast scanning UV detector and provides retention time and partial UV spectrum for component identification.The function of the software: data synchronization advanced noise filtering peak detection using information from all detection channels peak identification according to time and spectrum peak quantification without on-line calibration.
其他文献
  Surface plasmon resonance imaging (SPRi) [1-3] is a new, labeling-free and high-throughput analytical tool capable of imitating biological conditions and co
  A novel purge-assisted and temperature-controlled headspace solid-phase microextraction (PATC-HS-SPME) couple to gas chromatography-negative ion chemical io
  Highly sensitive separations of biogenic compounds by capillary electrophoresis (CE) and microchip electrophoresis (MCE) using an on-line sample concentrati
  Monolithic stationary phases show promise for LC as a result of their good permeability, ease of preparation and broad selectivity.However, the performance
  The characterization of quantum dots (QDs) bioconjugates is of great important in biological applications.Our group developed a useful method for characteri
会议
  A new approach to proteomic quantification and identification was developed to make full uses of multi-dimensional HPLC with high-sensitive fluorescence det
  We have developed a technology platform which has been referred to as multi-dimensional mass spectrometry-based shotgun lipidomics (MDMS-SL).MDMS-SL is comp
  Lipids are key regulators of brain function and have been implicated in various neurodegenerative diseases, such as human Parkinsons disease (PD) and Alzhei
  A strategy based on postcolumn electrophoretic mobility control (EMC) was developed to alleviate the adverse effects of ion pairing reagents and/or nonvolat